Literature DB >> 22581409

Bladder capacity on preoperative urodynamics may impact outcomes on transobturator male slings.

Jonathan N Warner1, Gwen M Grimsby, Mark D Tyson, Christopher E Wolter.   

Abstract

AIMS: Stress incontinence is frequently seen after prostate surgery. We sought to evaluate preoperative urodynamic (UDS) parameters on functional outcomes after transobturator male sling placement.
METHODS: 49 male patients with stress urinary incontinence (SUI) after radical prostatectomy or transurethral resection of the prostate underwent transobturator sling (TOS) placement from December 2008 through June 2011 (AdVance® and Virtue®). A retrospective review was performed of those patients who underwent preoperative UDS and had a minimum of 6 weeks of follow up. In total 38 patients were identified. There were 28 patients considered a success and 10 patients considered a failure. We then evaluated the preoperative UDS parameters between these two groups to identify potential adverse parameters.
RESULTS: Overall success rate was 74% (28/38) with an average follow up of 3 months. Comparing the success and failure groups there was no difference between the pre-operative parameters. On pre-operative UDS, only bladder capacity was found to be significantly lower in those who failed TOS. Univariate comparisons of sling outcomes stratified by bladder capacity tertiles was performed. These values were chosen as they represented the 25th, 50th, and 75th percentiles, respectively. All patients (10/10) with bladder capacities in the top tertile experienced success with the sling, compared to only 62% and 50% of patients in the 50th and 25th tertiles, respectively; these differences were significant (Fisher's exact P-value = 0.044).
CONCLUSION: TOS is an effective therapy for men with SUI. Bladder capacity based on pre-operative UDS may impact the success of the procedure.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22581409     DOI: 10.1002/nau.22233

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  7 in total

1.  Management of urinary incontinence after radical prostatectomy.

Authors:  Thomas R Jarvis; Jaspreet S Sandhu
Journal:  Curr Urol Rep       Date:  2014-07       Impact factor: 3.092

Review 2.  Valsalva leak point pressure (VLPP) greater than 70 cm H2O is an indicator for sling success: a success prediction model for the male transobturator sling.

Authors:  Divya Ajay; Arman A Kahokehr; Aaron C Lentz; Andrew C Peterson
Journal:  Int Urol Nephrol       Date:  2022-05-04       Impact factor: 2.370

3.  The extent of changes in the membranous urethra angle is associated with the outcome of retrourethral transobturator sling procedure.

Authors:  Irina Soljanik; Olga Solyanik; Christian G Stief; Ricarda M Bauer; Armin J Becker; Christian Gozzi; Sonja M Kirchhoff
Journal:  Int Urol Nephrol       Date:  2014-12-24       Impact factor: 2.370

Review 4.  Effect of preoperative urodynamic detrusor overactivity on post-prostatectomy incontinence: a systematic review and meta-analysis.

Authors:  Myong Kim; Myungchan Park; Myungsun Shim; Seung-Kwon Choi; Sang Mi Lee; Eun-Sik Lee; Cheryn Song; Myung-Soo Choo; Hanjong Ahn
Journal:  Int Urol Nephrol       Date:  2015-10-27       Impact factor: 2.370

5.  Evaluation of bladder diary parameters based on correlation with the volume at strong desire to void in filling cystometry.

Authors:  Sheng-Mou Hsiao; Chin-Fen Hsiao; Chi-Hau Chen; Ting-Chen Chang; Wen-Yih Wu; Ho-Hsiung Lin
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

Review 6.  Recent research on the role of urodynamic study in the diagnosis and treatment of male lower urinary tract symptoms and urinary incontinence.

Authors:  Yuan-Hong Jiang; Hann-Chorng Kuo
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2017 Apr-Jun

7.  Impact of obesity on male urethral sling outcomes.

Authors:  M Francesca Monn; Hannah V Jarvis; Thomas A Gardner; Matthew J Mellon
Journal:  Ther Adv Urol       Date:  2020-06-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.